Immunomedics Inc (IMMU)

Add to Watchlists
Create an Alert
13.29 +0.05  +0.38% NASDAQ Jun 20, 15:12 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/08/2019 17:00 EDT Misc Immunomedics Inc Second Quarter Earnings Conference Call in 2020
08/08/2019 Earnings Immunomedics Inc Second Quarter Earnings Results in 2019
06/03/2019 Misc Immunomedics Inc Annual General Meeting in 2018
05/09/2019 08:00 EDT Misc Immunomedics Inc First Quarter Earnings Conference Call in 2019
05/09/2019 Earnings Immunomedics Inc First Quarter Earnings in 2019 Release
02/25/2019 Misc Immunomedics Inc Annual Report in 2018
08/23/2018 17:00 EDT Misc Immunomedics Inc Fourth Quarter Earnings Conference Call in 2018
08/23/2018 Earnings Immunomedics Inc Fourth Quarter Earnings Results in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.immunomedics.com
  • Investor Relations URL: http://www.immunomedics.com/investors.shtml
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Aug. 08, 2019
  • Last Earnings Release: May. 09, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Immunomedics Inc is a clinical-stage biopharmaceutical company, based in the United States. The company develops monoclonal antibody-based products for the targeted treatment of cancer and autoimmune disorders, among others. Its portfolio of products under investigation include antibody-drug conjugates that target the tumor-reducing toxic effects of chemotherapeutic treatments. The company's pipeline includes products targeting solid tumors and hematologic malignancies, among other diseases in clinical and preclinical development. The company is marketing specific diagnostic imaging agents to detect bone infections in Europe, Canada, and Australia. The company has subsidiaries in the Netherlands and Germany to manage sales and clinical trials in Europe.

Top Fund Holders

Symbol Name Weighting
SMHCGX ST Healthcare Innovations 7 RE 3.14%
SBIO ALPS Medical Breakthroughs ETF 3.07%
ETCHX Eventide Healthcare & Life Sciences C 2.80%
SMZCX AlphaCentric Small Cap Opps C 1.42%
FPHAX Fidelity® Select Pharmaceuticals Port 1.16%
FBIOX Fidelity® Select Biotechnology 1.07%
LABU Direxion Daily S&P Biotech Bull 3X ETF 0.98%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("IMMU","name")
  • Description: =YCI("IMMU","description")
  • Sector: =YCI("IMMU","sector")
  • Industry: =YCI("IMMU","industry")
  • Est. Current Fiscal Year End: =YCI("IMMU","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.